Cookies are disabled so parts of this website may not function correctly, read more about cookies and how to enable them here  

Become a member

To apply for SBNS membership click the link below and visit our application page.

Find out more

Patient Information

SBNS is unable to give medical advice or recommend neurosurgeons. Please use an appropriate support group or your GP.

Find out more

Become a Neurosurgeon

The management of neurosurgical patients requires excellent medical and surgical skills, a career in Neurosurgery offers many challenges and rewards.

Find out more

More formation to follow*

SESSION 1  UK MULTI-CENTRE CLINICAL TRIALS:
ARE THEY PRACTICE CHANGING?
MW.2020_4_X_5.jpg

NERVES – Results of the Trial
Martin Wilby, Consultant Neurosurgeon, The Walton Centre NHS Trust, Liverpool, UK 

Extending medical training at Cambridge University (Girton College) to gain a PhD in Neuroscience under Prof James Fawcett paved way for Neurosurgical training at Leeds and Cambridge. Spinal fellowship at the Royal Adelaide from 2007-08 under Profs Freeman/Fraser. Appointed in 2009 at Liverpool to date with a practice mainly of complex spine. NERVES is the first direct comparison of steroid nerve root injection to surgery, it has taken a long time from application (2013/14) to fruition but is going to be published this year.

Peter_Hutchinson.jpg 

 

 

 

 

 

 

 

Launch of new NIHR Multicentre Trials

MAST

Peter Hutchinson, Professor of Neurosurgery, Addenbrookes’ Hospital, Cambridge, UK
Peter Hutchinson BSc (Hons), MBBS, PhD (Cantab), FRCS (Surg Neurol) FMedSci is Professor of Neurosurgery, NIHR Research Professor and Head of the Division of Academic Neurosurgery at the University of Cambridge.

He is Director of Clinical Research at the Royal College of Surgeons of England. He holds an Honorary Consultant Neurosurgeon post at Addenbrooke’s Hospital with a sub-specialist interest in the management of neuro-trauma, specifically head and traumatic brain injury.

He has a research interest in acute brain injury, utilising monitoring technology  to increase the understanding of the pathophysiology of brain injury, and in the investigation and treatment of concussion. He also leads the international RESCUE studies evaluating the role of decompressive craniectomy in traumatic brain injury. He was awarded the Olivecrona Prize (the “Nobel Prize for Neurosurgery”) for his work on cerebral metabolism in acute brain injury). He has co-authored over 500 publications (including NEJM,  Lancet and Brain) and been lead applicant in over £15m of grants (including MRC and NIHR). He is joint editor of the Oxford Textbook of Neurological Surgery and “Head Injury – A Multidisciplinary Approach”. 

 He is Director of Clinical Studies at Robinson College, Past President of Clinical Neurosciences Section of the Royal Society of Medicine, Director of the Research Fund of the European Association of Neurosurgical Societies, Treasurer of the International Neurotrauma Society and Chief Medical Officer for the Formula One British Grand Prix. 

 M_Jenkinson_4_X_5.jpg

 

 

 

STOP’EM
Michael Jenkinson, Professor of Neurosurgery, The Walton Centre NHS Trust, Liverpool, UK

Michael Jenkinson is Professor of Neurosurgery and Honorary consultant neurosurgeon at the University of Liverpool and Walton Centre NHS Foundation Trust.

He chairs the National Cancer Research Institute Brain Tumour Group, the Academic Committee of the Society of British Neurological Surgeons and is a member of Specialised Cancer Surgery CRG.

His research interests include meningioma and cerebral metastasis, and clinical studies on quality of life in brain tumours.  He is the chief investigator for the international, multi-centre ROAM-1308 trial (Radiation versus Observation following surgical resection of Atypical Meningioma), the KEATING trial (Ketogenic Diet in Glioma) and STOP ‘EM (Surgeons Trial Of Prophylaxis for Epilepsy in Meningioma).

 Rustam_portrait_2018_4_X_5.jpg

 

 

 

 

 

 

 

 

 

CARE
Rustam Al-Shahi Salman, Professor of Neurology, Western General Hospital, Edinburgh, UK 

Rustam Al-Shahi Salman is a professor of clinical neurology, head of the cerebrovascular research group, and clinical director of the Edinburgh Clinical Trials Unit at the University of Edinburgh, and an honorary consultant neurologist in NHS Lothian. He became interested in neurology during medical training in Cambridge and was inspired to work on common neurological problems by Charles Warlow and the stroke research group in Edinburgh, which he joined in 1998 as an MRC clinical training fellow, progressing to MRC patient-oriented clinician scientist and senior clinical fellowships until 2016. Rustam's clinical and research interests focus on the frequency, prognosis, treatment, and pathophysiology of intracranial haemorrhage, using research methods such as randomised controlled trials, community- or population-based cohort and case-control studies, brain banking, and meta-analysis. His clinical work includes acute TIA/stroke/neurology services and specialist outpatient clinics. Rustam was one of the lead authors of The Lancet's 2014 Series on Increasing Value and Reducing Waste in Research (http://www.thelancet.com/series/research and http://www.thelancet.com/campaigns/efficiency) and a founding member of the REWARD Alliance (http://rewardalliance.net). He has received funding from the MRC, British Heart Foundation, Stroke Association, Chest Heart and Stroke Scotland, the Chief Scientist Office of the Scottish Government, and GE Healthcare (see www.whopaysthisdoctor.org). Rustam welcomes contact from trainee doctors interested in pursuing independently-funded clinical research fellowships to answer important questions about stroke due to any form of intracranial haemorrhage. You can follow Rustam on Twitter at @BleedingStroke 

Mark_Kotter.jpg.png 

 

 

 

RECEDE
Mark Kotter, Clinical Lecture, Cambridge University, UK

Mark is a fellowship trained complex spine neurosurgeon and clinician scientist at the University of Cambridge.   His research focusses on stem cells, cellular reprogramming and regenerative medicine.  A technology developed by his group merging stem cell with synthetic biology has opened up novel opportunities for highly efficient and consistent production of cells for research, drug development and cell therapy.  Based on this technology he is the founder of two start-ups.  As a neurosurgeon, he specialises in spinal cord injury patients and seeks to develop novel regenerative medicine approaches; one approach is currently tested in RECEDE Myelopathy, the first regenerative medicine trial for degenerative cervical myelopathy.  He is also the founder of Myelopathy.org a charity supporting the commonest form of spinal cord injuries.


Paul_Brenam.jpg  DENS 
Paul Brenan, Senior Clinical Lecturer & Honorary Consultant, University of Edinburgh and NHS Lothian, Edinburgh, UK

Paul is Reader and Honorary Consultant Neurosurgeon at the University of Edinburgh and NHS Lothian. His research spans the laboratory and the clinic, combining molecular, epidemiology and clinical investigation to guide rationale innovation to improve patient care. He applies this strategy to improving diagnosis, treatment and outcomes for people with brain tumours, and traumatic brain injury and spinal injuries. He co-developed the GCS-pupils score, CGS Aid, and GCSP prognostic charts. As founder of University of Edinburgh spin-out, eoSurgical Ltd, he has also led innovation in surgical simulation training around the world. He is part of the CRUK Adult Brain Tumour Centre of Excellence, based on Edinburgh.  


SESSION 2 ONCOLOGY

philippe_schucht_014.jpg

 

GUEST SPEAKER 

Surgery for new and recurrent gliomas: how much makes sense?

Professor  Philippe Schucht, Head of Neurosurgical Oncology, University Hospital Bern, Switzerland

Philippe Schucht is a neurosurgeon at the University Hospital in Bern, Switzerland. He is in charge of the adult and pediatric neurosurgical oncology program, vice-chairman of the Department of Neurosurgery and head of the interdisciplinary Neuro-Oncology Center. His research activities are centered on novel technologies for intra-operative visualization of tumor tissue and neurological function. He is honorary president of the Swiss Young Neurosurgeons Society and runs an educational non-profit organization that builds neurosurgical capacity in South East Asia.

  GUEST SPEAKER

Phillip_Pearl.png

 

 

Medical Problems for Musical Masters
Phillip L. Pearl, MD, President, Child Neurology Society, Director of Epilepsy and Clinical Neurophysiology,  William G. Lennox Chair,  Boston Children's Hospital, USA 

Phillip L. Pearl, M.D. is Director of Epilepsy and Clinical Neurophysiology and William G. Lennox Chair in the Department of Neurology at Boston Children’s Hospital and Professor of Neurology at Harvard Medical School.  Dr. Pearl, originally from Baltimore, attended Johns Hopkins University, Peabody Conservatory of Music and University of Maryland School of Medicine.  He took his residency at Baylor College of Medicine in Houston and fellowship at Boston Children’s Hospital.  Dr. Pearl has published over 210 manuscripts, over 100 chapters and reviews, and authored or edited five books in the field of child neurology, two of which have been translated into Chinese and Japanese.  He is also on the faculty of the Music and Health Institute of the Berklee College of Music in Boston.  His major research interest is inherited metabolic epilepsies.  Dr. Pearl is Past President of the Professors of Child Neurology and currently President of the Child Neurology Society. 

SESSION 3 

CRANIAL RECONSTRUCTION

 Brad_Harrington.jpg

 

 

 

GUEST SPEAKER

Penetrating Brain & Spine Injuries

Brad Harrington, Brad Harrington. Consultant Neurosurgeon. Stellenbosch and Tygerberg Academic Hospital. Cape Town, South Africa

Dr Harrington is a neurosurgeon by training and a fellow of the College of Neurosurgeons of South Africa (FC Neurosurgery). He is currently a full-time researcher enrolled in a doctorate in neurosciences at Stellenbosch University.

He is also a consultant neurosurgeon at Tygerberg Academic Hospital in Cape Town, South Africa. His practice involves all aspects of general neurosurgery with a special interest in neurotrauma.

He is the research coordinator for the Division of Neurosurgery and actively involved in training and mentoring.

He also holds an engineering degree in mechanical engineering from the University of Witwatersrand.

  GUEST SPEAKER 

 Graham_Fieggen_photo.JPG

 

 

 

 

 

 

 

As if we didn’t have enough problems: Covid -19 hits South Africa  
Grahame Feiggen, Professor of Neurosurgery, Neurosciences Institute University of Cape Town

Graham Fieggen holds the Helen and Morris Mauerberger Chair of Neurosurgery at the University of Cape Town where he is Head of the Division of Neurosurgery and Head of the Department of Surgery. Graduating from medical school in 1987, he completed Internship at Groote Schuur Hospital before spending a year in London doing an MSc in Neuroscience, graduating with distinction. This was followed by two years in General Practice in Canada before returning to Cape Town to specialise in neurosurgery, gaining admission as a Fellow of the College of Neurosurgeons (SA) and earning the doctoral degree MD (Neurosurgery) from UCT.

Graham was appointed as a paediatric neurosurgeon at Red Cross War Memorial Children’s Hospital where he spent 10 years before taking up the Chair of Neurosurgery at UCT where he leads an exceptional team of 9 consultant neurosurgeons, 7 part-time consultants from the private sector and 12 trainees. In this position, he has led efforts to bring together neurosurgery, neurology and psychiatry in a Neuroscience Institute at UCT which will be constructed in 2018.

He is past President of the International Society for Pediatric Neurosurgery and the Society of Neurosurgeons of South Africa. He is very fortunate to be married to Karen, a paediatrician and medical geneticist, and they are proud parents of Josh and Liam.

 

SESSION 4

IMPACT OF COVID-19 ON UK NEUROSURGERY

A_King_2.jpg

 

 

 

 

 

 

L-Ra COVID-19 Trial

Andrew King, Prof. of Neurosurgery, Salford Royal NHS Foundation Trust, Manchester, UK

Qualifications: MBBS, London 1988, FRCS, England 2002, FRCS (Surgical Neurology) 2007.

Andrew King was appointed as a consultant neurosurgeon in Manchester in 1998. He trained in neurosurgery in Cambridge, London and Manchester after qualifying from The Royal London Hospital Medical College, University of London. 

His clinical subspecialty interest is skull base surgery. He is past President of the British Skull Base Society which, during his tenure as President, hosted the World Skull Base Congress in 2012 and started the National Acoustic Neuroma Database- the largest of its kind in the world.  

He was appointed Professor of Neurosurgery at the University of Manchester in 2012. His research interests include subarachnoid haemorrhage and skull base pathology.   


Stephen_Price_4_X_5.jpg

 

 

 

 

Results of Oncology COVID-19 Trials
Stephen Price, Consultant Neurosurgeon Addenbrooke's Hospital, Cambridge, UK

Stephen graduated in medicine from Bart’s Medical College in 1994 and did his basic surgical training in the East Midlands. He trained in neurosurgery in Nottingham and Romford before starting the Cambridge training scheme. Stephen was made Clinical Lecturer in 2005 and was appointed consultant neurosurgeon with a special interest in managing brain tumours in 2008. He is currently the network lead for brain tumours at the Anglian Cancer Network and is Co-Director of the Neuro-Oncology Programme at the Cambridge Cancer Centre. Stephen introduced 5-ALA fluorescence guided surgery to Cambridge to help maximise tumour removal and, with colleagues, regularly teach other surgeons how to use these methods. His practice is largely based around the surgical management of malignant brain tumours (gliomas and metastases). He has recently been awarded a NIHR Career Development Fellowship to develop a precision surgery programme. His research group uses advanced imaging methods to study the invasion and impact of tumours on the normal brain surrounding brain tumours. This work aims to better outline the invasive margin of these tumours and understand the effect of these tumours and treatment on the functioning of the normal brain. He is a Fellow of Queens’ College and is the Director of Studies of Clinical Medicine.

Dan_Fountain.jpg

 

Dan Fountain, Salford Royal NHS Foundation Trust, Manchester, UK
NIHR Academic Clinical Fellow in Neurosurgery at Salford Royal and the University of Manchester. Currently undertaking research funded by Cancer Research UK into the molecular basis for aggressive skull base meningiomas.

 



   Nigel_Mendoza_4_X_5.jpg

 

 

Results of COVID-19 and Pituitary Surgery Survey; the early days
Nigel Mendoza, Consultant Neurosurgeon, Charing Cross Hospital, London, UK

Nigel Mendoza has been a Consultant Neurosurgeon at Charing Cross Hospital, Imperial College Healthcare NHS Trust in London since 1995. His neurosurgery practice is based around pituitary and skull base surgery (including trigeminal neuralgia and acoustic neuromas). His surgical expertise also includes minimally invasive techniques, extended endoscopic approaches to the skull base and stereotactic radiosurgery. 

He continues to couple his clinical practice with his commitment to teaching and the development of higher surgical trainees. He is actively involved in medical education within his department as well being a regular attendee of national and international neurosurgical meetings.

He was appointed  Treasurer of the  SBNS in 2018.

   Paul_Grundy.jpg

 

How has Covid-19 impacted on the national neurosurgical waiting list?
(And what can we do about it?)

Paul Grundy, Consultant Neurosurgeon, University Hospital Southampton, Southampton, UK

Mr Paul Grundy is a consultant neurosurgeon and acting Medical Director at University Hospital Southampton NHS FT. He has a clinical practice dedicated to adult cranial neuro-oncology with particular interests in day-case, short-stay surgery, awake craniotomy and shared decision making. He is president elect (VP) of BNOS, honorary secretary of SBNS and NHSEI neurosciences CRG vice-chair, SRS ERG chair and lead of the national neurosurgical service transformation program.


 K_S_Manjunath_Prasad.jpg

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Impact of Covid-19 on neurosurgery activity and mortality in the United Kingdom
and Republic of Ireland- A national SBNS and BNTRC study

Manjunath Prasad, Consultant Neurosurgeon, James  Cook University Hospital. Middlesbrough, UK
 

Education & Training 
  • M.B.B.S., University of Mysore, India
  • M.S., PGIMER, Chandigarh, India
  • M.Chir (Neurosurg)., PGIMER, Chandigarh, India
  • FRCS (Neurosurg)- Northern Deanery
  • M ClinEd., Newcastle University 
 Professional Interests
  • Skull base surgery
  • Neurovascular diseases
  • Neurotrauma
  • Craniovertebral junction disorders
  • Clinical and translational research
  • Medical Education
Research
Founder member – Space for paralysis and Brain Computer Interface Lab – In association with Durham University

Founder member –Teesside Aneurysm Group – In association with Durham University Professional Affiliations 

  • Neurological Society of India
  • Society of British Neurological Surgeons
  • British Neurovascular Group
  • British Neurotrauma Group
  • British Skull Base Society
  • British Association of Spinal Surgeons
  • European Brain Injury Consortium
  GUEST SPEAKER

 picture_Khochfar.png

 

Super-massive Black Holes: Monsters at the heart of galaxies

Sadegh Khochfar, Professor  and Chair of Theoretical Astrophysics, University of Edinburgh, UK

Sadegh Khochfar is Professor and Chair in Theoretical Astrophysics at the University of Edinburgh. He received his PhD from the University of Heidelberg and was previously an Independent Max-Planck Research Group Leader at the Max-Planck Institute for Extraterrestial Physics in Garching and Departmental Lecturer at Oxford University. His research interests focus on the formation and evolution of galaxies and black holes in the Universe using theoretical and computational methods.

 

 

 

 

 


Last Updated: 26 October 2020